Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has provided an update.
China Resources Pharmaceutical Group Ltd. has announced the composition of its board of directors and their respective roles within the organization. This announcement is significant as it outlines the leadership structure, which is crucial for the company’s strategic direction and governance, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is positioned in the market as a key player in providing healthcare solutions.
Average Trading Volume: 12,295,656
Technical Sentiment Signal: Sell
Current Market Cap: HK$32.23B
For a thorough assessment of 3320 stock, go to TipRanks’ Stock Analysis page.